Beyond the fusion gene: uncovering an RNA surveillance checkpoint in leukemia
What if the aggressiveness of a leukemia fusion isoform depends not only on how it is produced, but on whether the cell destroys its RNA? Our study reveals how EIF4A3-dependent NMD buffers AML1-ETO9a dosage and shapes outcome in t(8;21) AML.
